Clinical Trial Cost Estimator

Clinical Trial Costs are a Black Box

CRO Quotes

Only for trials you're about to run, often 50%+ off target, not available for early planning or competitive analysis

Back-Channel Estimates

"We heard Company X spent" - inconsistent, not specific to your trial, may not stand up to board and investor scrutiny

Manual Research

Hours hunting through SEC filings for comparable trials with incomplete cost breakdowns and heavy guesswork

Industry Averages Don't Reflect Reality

Published benchmarks ($40K/patient for Phase 3) don't account for your specific protocol, geography, or therapeutic area complexity

Systematic, Transparent Trial Cost Analysis

Biotech Finance Teams

Investment Banks

Investment Funds

Early Portfolio Planning

Model P1→P2→P3 costs across your platform before committing resources

Upload your own protocols for analysis
Compare costs across indications
Plan multi-year development budgets

Board and Investor Reporting

Defensible numbers for investor and board presentations

Compare cost per patient, enrollment rate to industry averages
Transparent methodology you can explain
Detailed cost component breakdowns
See what competitors actually spent

CRO Quote Validation

Pressure-test vendor estimates with independent methodology

Systematic cost breakdown analysis
Identify over/under-priced components
Negotiate from position of knowledge

Save Hours Crawling Through Filings

Automatically identify the most relevant comps and extract detailed cost data

Detailed analysis of why trials are comparable to your target trial
Automated extraction of the most relevant cost data in each filing
Clear explanation of any assumptions made
Saves days of work: all you do is click a button

Quick Analysis for Live Deals

Fast, auditable cost estimates for time-sensitive projects

Get initial cost estimates in minutes, and comparable trial analysis in hours
Transparent, consistent methodology so you can confidently present results
Tweak parameters and see results instantly

Provide Value-Added Analysis

Help your clients develop more transparent cost estimates

Estimating trial costs is challenging for startups: give them a leg up
Enhanced due diligence capabilities
Improved client advisory offerings

Independently Validate Estimates

Don't rely solely on management estimates for due diligence

Benchmark cost and enrollment rate to sanity check management estimates
Independent cost verification methodology
Analyze protocols for prospective trials
Reduce dependence on management estimates

Investment Decision Support

Consistent cost analysis framework for investment evaluation

Systematic cost assessment approach
Transparent assumption documentation
Investment committee presentation support
Risk assessment through cost analysis

Portfolio Analysis

Standardized cost methodology across portfolio companies

Consistent analysis framework
Cross-portfolio benchmarking capabilities
Investment performance evaluation
Portfolio optimization insights

How It Works

Input: NCT06411379 - Alzheimer's Phase 3 OR upload protocol document

Your Trial Cost Estimate: $32.2M total
• CRO & Patient Costs: $23.1M
• Study Drug: $3.3M | Overhead: $5.8M

5 Comparable Trials Found: *
• 2 with SEC cost data: $28-31M range (estimated from filings)
• Your enrollment rate: 2.3 pts/site/month vs 1.8 benchmark
• Eligibility overlap analysis: 68% patient pool overlap
• Risk flags: 1 comparable had enrollment target changes

See What You Get

Complete cost breakdown with transparent methodology

Find similar trials automatically with quantified similarity scores for each dimension

Detailed cost data extracted from SEC filings (where available)

Identify which trials are competing for the same patient population

Get Access

In-depth trial cost analysis

Detailed AI trial cost estimates
Protocol upload capability
Email support
Complete methodology explanations
Enrollment rate benchmarks
Trial similarity scoring
Execution risk flags
SEC cost data (when available)

Schedule a demo

Frequently Asked Questions

How does this differ from CRO cost estimates?

CRO quotes are only available for trials you're about to run. Our tool works for early planning, competitive analysis, and validation of vendor estimates. You can analyze any trial with an NCT ID or upload your own protocols before registration.

Can I analyze proprietary protocols that are not in clinicaltrials.gov?

Yes - upload protocol documents for analysis during development planning phases. This enables cost modeling before NCT registration and supports strategic decision-making. We do not save any protocols you provide to our database. Cost estimates are available for uploaded protocols, but our system currently does not support comparable trial analysis from protocol uploads.

What is the underlying methodology?

For target trials, our AI system generates estimates based on established academic research with systematic analysis of protocol complexity, therapeutic area factors, and geographic considerations. All assumptions and calculations are fully documented in every analysis. The system also automatically identifies comparable trials and estimates trial costs from SEC filings where available.

How much does it cost to use this?

We offer flexible pricing packages based on your needs. Whether you are a startup planning a Phase 1 trial or an investor analyzing a few trials a week, we can create a package that meets your needs.

Defensible Clinical Trial Cost Estimates